Publication: Screening of the anti-proliferative effects of baicalein and carbon nanodot combination on hela cancer cells
Loading...
Date
2025-01
Authors
Partheeban, Yugaashini
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This study identifies the anti-proliferative effects of a novel combination therapy using baicalein, a flavonoid, and carbon nanodots (CDs) on HeLa cervical cancer cells. Baicalein, known for its potent anti-cancer properties, has shown limitations in clinical applications due to low bioavailability. Carbon nanodots, with their excellent biocompatibility, solubility, and drug delivery potential, were used as a carrier to enhance the therapeutic efficacy of baicalein. The study evaluated the anti-proliferative effects of the baicalein-carbon nanodot (Bai-CDs) combination in comparison to standalone treatments of baicalein, CDs, and cisplatin on HeLa cells using the MTT assay. Results demonstrated that the combination therapy significantly inhibited cell proliferation in a dose-dependent manner with the IC50 69.85 ± 4.145μg/ml and p-value less than 0.05. These findings highlight the potential of the Bai-CDs combination as a new therapeutic strategy for cervical cancer, providing enhanced bioavailability and targeted anti-cancer effects while minimizing adverse outcomes associated with conventional chemotherapy
Description
Keywords
-